Is Nektar Therapeutics (NKTR) a Buy, Sell, or Hold?
NASDAQ : NKTR
Nektar Therapeutics — Analyst Ratings
$71.35 USD
$0.62 (0.88%)
- Volume
- 649.84K
- Average Volume
- 1.03M
- Market Capitalization
- $1.39B
- P/E Ratio
- -8.47
- Dividend Yield
- 0.00%
- Price Target
- $152.00
- Year High
- $109.00
- Year Low
- $21.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.21
Analyst Consensus Summary
Consensus Rating
Strong Sell
33 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-53.1%
vs Current Price
Price Target
$152.00
Average TargetPrice Target Range
Lowest Target
$80.00
-10.8% DOWNSIDE
Average Target
$152.00
Median Estimate
Highest Target
$192.00
-62.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 33
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 22 | 6 | 5 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Edward Nash | $153 | $68.67 | 2026-07-22 05:16 AM | 122.8% |
| Wedbush | Martin Fan | $80 | $81.89 | 2026-05-11 07:51 AM | -2.3% |
| Piper Sandler | Yasmeen Rahimi | $192 | $83.37 | 2026-05-08 07:07 AM | 130.3% |
| Oppenheimer | Jay Olson | $140 | $73.27 | 2026-03-13 12:39 PM | 91.1% |
| Piper Sandler | Yasmeen Rahimi | $105 | $36.35 | 2026-01-26 08:56 AM | 188.9% |